Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 12 and 21 years old
- You have reached at least a mid-level stage of physical puberty development (confirm with trial site)
- You have been diagnosed with Type 2 diabetes based on standard medical guidelines
- Your recent blood sugar control test (called a hemoglobin A1c) shows a result below 9%
- You are willing and able to follow the study schedule, including required visits, eating plans, and fasting periods
Who may not be able to join:
- You have previously been diagnosed with Prader-Willi Syndrome, a brain tumor, or obesity caused by a brain condition called hypothalamic obesity
- You have a serious developmental or intellectual disability
- You have been diagnosed with, or have symptoms of, an eating disorder such as anorexia nervosa, bulimia nervosa, or binge-eating disorder
- A parent or guardian has indicated that you are unable to take part in the study activities — for example, being unable to wear a continuous glucose monitor or unable to have imaging scans done without sedation
- You have had or are planning to have weight loss (bariatric) surgery
- You are currently taking or planning to take certain weight loss or diabetes medications, such as phentermine, topiramate, orlistat, GLP-1 medications, naltrexone, or bupropion (confirm with trial site if unsure about your medications)
- You are currently taking part in another weight loss research study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alaina Vidmar, MD, Children's Hospital Los Angeles
Phone: 323-361-3385
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in percent time in range; Change in Hemoglobin A1c; Change in insulinogenic index; Change in total body fat mass (kg)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.